L-Nutra vs Noom
Side-by-side comparison of AI visibility scores, market position, and capabilities
L-Nutra created the patented ProLon Fasting Mimicking Diet, backed by 25+ years of USC longevity research and 37 clinical studies; a 2024 Nature Communications study showed 2.5-year biological age reduction after 3 cycles.
About
L-Nutra is a nutri-technology company pioneering nutrition for longevity through evidence-based dietary programs and plant-based therapies. Founded by Dr. Valter Longo — director of the USC Longevity Institute and one of the world''s leading longevity scientists — L-Nutra commercializes decades of academic research into practical consumer and clinical nutrition products. Its flagship product, ProLon, is the world''s first patented Fasting Mimicking Diet (FMD): a 5-day proprietary nutrition program that provides carefully calibrated calories and macronutrients to trigger the cellular rejuvenation and metabolic benefits of fasting while allowing food consumption. ProLon is backed by 25+ years of scientific research, tested across 37 clinical studies, and protected by 134 global patents.
Noom is a digital weight health program combining psychology-based behavioral coaching, food logging, and human coaching to help members build sustainable healthy habits.
About
Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to behavior change. The platform combines daily lessons on cognitive behavioral techniques, food logging with a traffic-light color-coding system, personal coaching from trained health coaches, and group support to help members change their relationship with food and exercise. Noom raised over $540M and reached a $3.7B valuation, establishing it as a leading consumer digital health company. The company has expanded beyond weight loss into a broader weight health platform addressing both weight management and weight-related conditions including type 2 diabetes management with its Noom Med offering that includes GLP-1 medication prescribing. As GLP-1 medications like Ozempic and Wegovy have transformed the weight loss market, Noom has positioned its behavioral coaching as essential to sustainable results alongside medication. The platform serves both direct-to-consumer subscribers and employer health plans that offer Noom as a weight management benefit for their workforces.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.